148 related articles for article (PubMed ID: 23435421)
1. PTPN12 promotes resistance to oxidative stress and supports tumorigenesis by regulating FOXO signaling.
Harris IS; Blaser H; Moreno J; Treloar AE; Gorrini C; Sasaki M; Mason JM; Knobbe CB; Rufini A; Hallé M; Elia AJ; Wakeham A; Tremblay ML; Melino G; Done S; Mak TW
Oncogene; 2014 Feb; 33(8):1047-54. PubMed ID: 23435421
[TBL] [Abstract][Full Text] [Related]
2. Loss of PTPN12 Stimulates Progression of ErbB2-Dependent Breast Cancer by Enhancing Cell Survival, Migration, and Epithelial-to-Mesenchymal Transition.
Li J; Davidson D; Martins Souza C; Zhong MC; Wu N; Park M; Muller WJ; Veillette A
Mol Cell Biol; 2015 Dec; 35(23):4069-82. PubMed ID: 26391955
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer.
Nair A; Chung HC; Sun T; Tyagi S; Dobrolecki LE; Dominguez-Vidana R; Kurley SJ; Orellana M; Renwick A; Henke DM; Katsonis P; Schmitt E; Chan DW; Li H; Mao S; Petrovic I; Creighton CJ; Gutierrez C; Dubrulle J; Stossi F; Tyner JW; Lichtarge O; Lin CY; Zhang B; Scott KL; Hilsenbeck SG; Sun J; Yu X; Osborne CK; Schiff R; Christensen JG; Shields DJ; Rimawi MF; Ellis MJ; Shaw CA; Lewis MT; Westbrook TF
Nat Med; 2018 May; 24(4):505-511. PubMed ID: 29578538
[TBL] [Abstract][Full Text] [Related]
4. Pathologic Oxidation of PTPN12 Underlies ABL1 Phosphorylation in Hereditary Leiomyomatosis and Renal Cell Carcinoma.
Xu Y; Taylor P; Andrade J; Ueberheide B; Shuch B; Glazer PM; Bindra RS; Moran MF; Linehan WM; Neel BG
Cancer Res; 2018 Dec; 78(23):6539-6548. PubMed ID: 30297534
[TBL] [Abstract][Full Text] [Related]
5. Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase.
Sun T; Aceto N; Meerbrey KL; Kessler JD; Zhou C; Migliaccio I; Nguyen DX; Pavlova NN; Botero M; Huang J; Bernardi RJ; Schmitt E; Hu G; Li MZ; Dephoure N; Gygi SP; Rao M; Creighton CJ; Hilsenbeck SG; Shaw CA; Muzny D; Gibbs RA; Wheeler DA; Osborne CK; Schiff R; Bentires-Alj M; Elledge SJ; Westbrook TF
Cell; 2011 Mar; 144(5):703-18. PubMed ID: 21376233
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of protein tyrosine phosphatase PTPN12 in triple-negative breast cancer.
Thummuri D; Kumar S; Surapaneni SK; Tikoo K
Life Sci; 2015 Jun; 130():73-80. PubMed ID: 25817229
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of PTPN12 expression in human breast cancer.
Xunyi Y; Zhentao Y; Dandan J; Funian L
Braz J Med Biol Res; 2012 Dec; 45(12):1334-40. PubMed ID: 23044628
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine phosphatases in the HER2-directed motility of ovarian cancer cells: Involvement of PTPN12, ERK5 and FAK.
Villa-Moruzzi E
Anal Cell Pathol (Amst); 2011; 34(3):101-12. PubMed ID: 21483099
[TBL] [Abstract][Full Text] [Related]
9. PTPN12 Affects Nasopharyngeal Carcinoma Cell Proliferation and Migration Through Regulating EGFR.
Lin Q; Wang H; Lin X; Zhang W; Huang S; Zheng Y
Cancer Biother Radiopharm; 2018 Mar; 33(2):60-64. PubMed ID: 29634414
[TBL] [Abstract][Full Text] [Related]
10. Low expression of tyrosine-protein phosphatase nonreceptor type 12 is associated with lymph node metastasis and poor prognosis in operable triple-negative breast cancer.
Wu MQ; Hu P; Gao J; Wei WD; Xiao XS; Tang HL; Li X; Ge QD; Jia WH; Liu RB; Xie XM
Asian Pac J Cancer Prev; 2013; 14(1):287-92. PubMed ID: 23534739
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor genes and ROS: complex networks of interactions.
Vurusaner B; Poli G; Basaga H
Free Radic Biol Med; 2012 Jan; 52(1):7-18. PubMed ID: 22019631
[TBL] [Abstract][Full Text] [Related]
12. A loss-of-function screen for phosphatases that regulate neurite outgrowth identifies PTPN12 as a negative regulator of TrkB tyrosine phosphorylation.
Ambjørn M; Dubreuil V; Miozzo F; Nigon F; Møller B; Issazadeh-Navikas S; Berg J; Lees M; Sap J
PLoS One; 2013; 8(6):e65371. PubMed ID: 23785422
[TBL] [Abstract][Full Text] [Related]
13. A missense variant in PTPN12 associated with the risk of colorectal cancer by modifying Ras/MEK/ERK signaling.
Shen N; Li L; Xu W; Tian J; Yang Y; Zhu Y; Gong Y; Ke J; Gong J; Chang J; Zhong R; Miao X
Cancer Epidemiol; 2019 Apr; 59():109-114. PubMed ID: 30731403
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.
Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS
Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674
[TBL] [Abstract][Full Text] [Related]
15. Important roles of protein tyrosine phosphatase PTPN12 in tumor progression.
Lee C; Rhee I
Pharmacol Res; 2019 Jun; 144():73-78. PubMed ID: 30959160
[TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine phosphatase nonreceptor type 12 suppresses the proliferation of renal cell carcinoma by inhibiting the activity of the PI3K/mTOR pathway.
Piao YR; Jin ZH
J BUON; 2015; 20(5):1258-66. PubMed ID: 26537073
[TBL] [Abstract][Full Text] [Related]
17. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
Shats I; Gatza ML; Liu B; Angus SP; You L; Nevins JR
Cancer Res; 2013 Oct; 73(19):6056-67. PubMed ID: 23966291
[TBL] [Abstract][Full Text] [Related]
18. PTPN12 controls PTEN and the AKT signalling to FAK and HER2 in migrating ovarian cancer cells.
Villa-Moruzzi E
Mol Cell Biochem; 2013 Mar; 375(1-2):151-7. PubMed ID: 23212450
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Phosphotyrosine Phosphatases in Hepatocellular Carcinoma.
Zhangyuan G; Yin Y; Zhang W; Yu W; Jin K; Wang F; Huang R; Shen H; Wang X; Sun B
Cell Physiol Biochem; 2018; 46(6):2335-2346. PubMed ID: 29742497
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of tyrosine-protein phosphatase nonreceptor type 12 expression in nasopharyngeal carcinoma.
Zhang XK; Xu M; Chen JW; Zhou F; Ling YH; Zhu CM; Yun JP; Cai MY; Luo RZ
Tumour Biol; 2015 Jul; 36(7):5201-8. PubMed ID: 25663493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
